TABLE 1.
Patient no. | Age (y) | BW (kg) | Dose (MBq) | PSA (ng/mL) | Primary staging | Restaging | Primary therapy | Further prostate-specific therapy |
1 | 64 | 67 | 120 | 0.7 | x | RPE | No | |
2 | 67 | 73 | 132 | 8.5 | x | EBRT | ADT until 5 mo before PET/CT | |
3 | 77 | 68 | 127 | 28 | x | NA | No | |
4 | 59 | 73 | 124 | 0.3 | x | RPE | No | |
5 | 76 | 70 | 143 | 14.7 | EBRT | ADT until 2 mo before PET/CT | ||
6 | 63 | 74 | 160 | 96.7 | x | NA | No | |
7 | 75 | 72 | 128 | 4 | x | RPE | Under ADT | |
8 | 81 | 81 | 167 | 0.3 | x | RPE | No | |
9 | 60 | 85 | 177 | 0.3 | x | RPE | RTx and ADT until 3 y before PET/CT | |
10 | 69 | 81 | 156 | 1.5 | x | RPE | No | |
11 | 71 | 100 | 192 | 0.2 | x | RPE | No |
PSA = prostate-specific antigen level; RPE = radical prostatectomy; EBRT = external-beam radiation therapy; ADT = androgen deprivation therapy; NA = not applicable; RTx = radiation therapy.